AI Article Synopsis

  • The oral microbiome significantly influences both health and disease, with oral microorganisms, particularly lactobacilli, playing a key role in limiting fungal infections such as oropharyngeal candidiasis (OPC).
  • Strain MT4, an oral lactobacilli isolated from mice, is dominant in the oral mucosa and exhibits chitinase activity that damages the cell walls of fungi, reducing the severity of OPC.
  • The research highlights strain MT4’s potential as a novel probiotic therapy for managing oral fungal infections and emphasizes the importance of oral bacteria interactions in maintaining oral health.

Article Abstract

Unlabelled: The oral microbiome is a critical determinant of health and disease, as interactions between oral microorganisms can influence their physiology and the development or severity of oral infections. Lactobacilli have a widely recognized antagonistic relationship with and may exhibit probiotic properties that limit oral fungal infection. We previously reported that strain MT4, an oral strain isolated from C57BL/6 mice, can induce global changes in the murine oral microbiome and has anti- activity . To build on this information, we analyzed its abundance on the mouse oral mucosa, tested its impact on the severity and progression of oropharyngeal candidiasis (OPC) in a mouse model, and further explored the mechanism of antifungal activity . Our findings reveal that MT4 is a dominant cultivable in the oral mucosa of C57BL/6 mice. Strain MT4 has chitinase activity against , which damages the cell wall and compromises fungal metabolic activity. Oral inoculation with strain MT4 causes a reduction in the -induced rise in the abundance of oral enterococci and oral mucosal damage. This research underscores the potential of strain MT4 as a novel probiotic agent in the prevention or management of OPC, and it contributes to a better understanding of the role of oral bacterial microbiota role in the pathogenesis of fungal infections.

Importance: The interactions between the opportunistic pathogen and resident oral bacteria are particularly crucial in maintaining oral health. Emerging antifungal drug-resistant strains, slow-paced drug discovery, and the risk of side effects can compromise the effectiveness of current treatments available for oropharyngeal candidiasis. This study advances the search for alternative microbiome-targeted therapies in oral fungal infections. We report that strain MT4 prevents the -induced bloom of dysbiotic oral enterococci and reduces oral mucosal lesions in an oropharyngeal candidiasis murine model. We also show that this strain directly compromises the cell wall and reduces fungal metabolic activity, partly due to its chitinase activity.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11481578PMC
http://dx.doi.org/10.1128/mbio.02416-24DOI Listing

Publication Analysis

Top Keywords

strain mt4
20
oral
18
oral mucosa
12
chitinase activity
12
cell wall
12
oropharyngeal candidiasis
12
murine oral
8
compromises fungal
8
oral microbiome
8
oral fungal
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!